- Home
- YMAB vs NAT Comparison
YMAB vs NAT Comparison
Compare YMAB & NAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YMAB
- NAT
- Stock Information
- Founded
- YMAB 2015
- NAT 1995
- Country
- YMAB United States
- NAT Bermuda
- Employees
- YMAB N/A
- NAT N/A
- Industry
- YMAB Biotechnology: Pharmaceutical Preparations
- NAT Marine Transportation
- Sector
- YMAB Health Care
- NAT Consumer Discretionary
- Exchange
- YMAB Nasdaq
- NAT Nasdaq
- Market Cap
- YMAB 631.1M
- NAT 641.0M
- IPO Year
- YMAB 2018
- NAT 1997
- Fundamental
- Price
- YMAB $11.14
- NAT $2.98
- Analyst Decision
- YMAB Strong Buy
- NAT Hold
- Analyst Count
- YMAB 8
- NAT 2
- Target Price
- YMAB $21.38
- NAT $3.75
- AVG Volume (30 Days)
- YMAB 268.9K
- NAT 2.7M
- Earning Date
- YMAB 11-08-2024
- NAT 11-27-2024
- Dividend Yield
- YMAB N/A
- NAT 16.11%
- EPS Growth
- YMAB N/A
- NAT N/A
- EPS
- YMAB N/A
- NAT 0.29
- Revenue
- YMAB $84,553,000.00
- NAT $364,249,000.00
- Revenue This Year
- YMAB $10.24
- NAT N/A
- Revenue Next Year
- YMAB $20.21
- NAT $11.06
- P/E Ratio
- YMAB N/A
- NAT $10.27
- Revenue Growth
- YMAB N/A
- NAT N/A
- 52 Week Low
- YMAB $5.17
- NAT $2.95
- 52 Week High
- YMAB $20.90
- NAT $4.64
- Technical
- Relative Strength Index (RSI)
- YMAB 25.01
- NAT 30.59
- Support Level
- YMAB $12.47
- NAT $2.95
- Resistance Level
- YMAB $15.69
- NAT $3.12
- Average True Range (ATR)
- YMAB 0.97
- NAT 0.10
- MACD
- YMAB -0.46
- NAT -0.01
- Stochastic Oscillator
- YMAB 9.88
- NAT 6.10
About YMAB Y-mAbs Therapeutics Inc.
Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.
About NAT Nordic American Tankers Limited
Nordic American Tankers Ltd owns and operates double hull crude oil tankers. It is an international tanker company that owns double-hull Suezmax tankers. It operates vessels in the spot market or on spot market-related charters pursuant to cooperative arrangements with third parties. The company's fleet consists of crude oil tankers, and all of its vessels are employed in the spot market. The company has only one type of vessel - Suezmax crude oil tankers. It operates in markets that are very competitive and based mainly on supply and demand.